Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis
Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32
DOI: 10.1177/10760296261427166 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 03.03.2026. Verfasst von Muhammad Hassan Waseem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Allama Iqbal Medical College, Lahore, Pakistan. Hauptthemen laut MEDLINE: Anticoagulants, Intracranial Thrombosis, Venous Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Cerebral venous thrombosis (CVT) is a rare but severe type of stroke, typically treated with vitamin K antagonists (VKAs). This study compares different direct oral anticoagulants (DOACs) with VKAs for the management of CVT.
Methods
PubMed, Cochrane Central, and ScienceDirect were searched up to May 2025. A network meta-analysis using a frequentist approach was performed in RStudio version 4.3.3. P-scores were used to rank treatments. The evaluated outcomes included full recanalization, recurrent venous thromboembolism (VTE), major hemorrhage, intracranial hemorrhage (ICH), and mortality. The Cochrane Risk of Bias (RoB 2.0) tool and the Newcastle-Ottawa Scale (NOS) were employed to assess the quality of randomized controlled trials (RCTs) and observational studies.
Results
Our analysis included 16 studies involving 1403 patients. We found that various DOACs, including apixaban, dabigatran, and rivaroxaban, had rates of full recanalization, VTE recurrence, major hemorrhage, ICH, and mortality comparable to those of VKAs. VKAs showed the highest likelihood of full recanalization, with a P-score of 0.70, whereas apixaban had the lowest, with a P-score of 0.04. For reducing recurrent VTE rates, apixaban was the most effective (P-score = 0.83), and dabigatran the least (P-score = 0.04). Apixaban also led to the greatest reduction in ICH risk (P-score = 0.70), while rivaroxaban had the lowest likelihood (P-score = 0.29). Regarding major hemorrhage, apixaban had the highest probability of reduction (P-score = 0.81), with VKAs performing worst (P-score = 0.26). Lastly, apixaban ranked highest for reducing mortality (P-score = 0.78), whereas VKAs ranked lowest (P-score = 0.39).
Conclusion
DOACs showed no significant differences in rates of full recanalization, VTE recurrence, major hemorrhage, ICH, or mortality compared with VKAs. Apixaban had the highest probability of reducing VTE recurrence, mortality, and hemorrhagic events, whereas VKAs had the highest probability of achieving full recanalization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allama Iqbal Medical College, Lahore, Pakistan.
- King Edward Medical University, Lahore, Pakistan.
- Cooper University Hospital, Camden, USA.
- Saidu Medical College, Swat, Pakistan.
- Jinnah Sindh Medical University, Karachi, Pakistan.
- Sotang Primary Hospital, Solukhumbu, Nepal.
ORCID-Profile: Muhammad Hassan Waseem, Pawan Kumar Thada
Zitieren
APA
Waseem, M. H., Abideen, Z. U., Rissardo, J. P., Khan, M. H., Farhan, K., Fornari Caprara, A. L., Thada, P. K., & Dmytriw, A. A. (2026). Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261427166
Vancouver
Waseem MH, Abideen ZU, Rissardo JP, Khan MH, Farhan K, Fornari Caprara AL, et al. Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261427166
BibTeX
@article{Waseem2026,
author = {Waseem, Muhammad Hassan and Abideen, Zain Ul and Rissardo, Jamir Pitton and Khan, Muhammad Haris and Farhan, Kanza and Fornari Caprara, Ana Leticia and Thada, Pawan Kumar and Dmytriw, Adam A},
title = {Comparing Efficacy and Safety of Different Anticoagulants in Cerebral Venous Thrombosis: A Systematic Review and Network Meta-Analysis},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2026},
volume = {32},
doi = {10.1177/10760296261427166}
}
EUVIMED